ELMMB logo
Facebook logo Twitter logo

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 11th October 2023       MHRA Press Release: SteriFeed colostrum collector not to be used to directly feed babies due to choking risk, 
                                         MHRA advises.
 15th September 2023 MHRA News:  MHRA approves Moderna’s adapted COVID-19 vaccine (Spikevax) that targets Omicron XBB.1.5


MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

application/pdfB Braun Medical Class 2 meds recall_various products_EL_23_A27_310723.pdf (148KB)31/07/2023Download
 Brief description of the problem B. Braun Medical Limited is recalling the specific product batches as a precautionary measure after traces of midazolam were detected in the batches listed in this... 
application/pdfPholcodine containing products class 2 meds recall EL_A_23_09.pdf (172KB)14/03/2023Download
 Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodinecontaining medicines are being recalled and withdrawn from the UK as a precaution. The Commission on... 
application/pdfClexane 10000IU per 1ml syringes Star Pharm_class 4 meds defect EL_22_A08.pdf (135KB)09/03/2023Download
 Drugsrus Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Clexane 10,000IU (100mg)/1 ml Syringes contains a typographical error in the... 
application/pdfMethadone 1mg per mL Oral Solution BP_ T&R Cl 4 meds recall EL_23_A07.pdf (203KB)07/03/2023Download
 Thornton & Ross Ltd has informed the MHRA that specific batches of Methadone 1mg/mL Oral Solution BP Sugar Free have been packaged with the incorrect Product Information Leaflet (PIL). The incorrect ... 
application/pdfLevothyroxine 12.5mcg tablets mar23 EL_23_A06_Final.pdf (112KB)02/03/2023Download
 Teva UK Limited is recalling the above batch of Levothyroxine 12.5mcg Tablets in response to a lower than required assay result discovered during routine stability testing. 
application/pdfOxycodone HcL 10mg per 1ml oral soln Cl 4 meds recall_291122.pdf (94KB)29/11/2022Download
 Lucis Pharma Ltd has informed the MHRA that there is a typographical error with text on the rear side of the outer packaging for Oxycodone Hydrochloride 10mg/ml Oral Solution. The text incorrectly... 
application/pdfVenlafaxine XL 300mg PR tabs_martindale Cl4 meds recall EL22_A_47_nov22.pdf (61KB)17/11/2022Download
application/pdfStemetil Syrup 5mg per 5ml Class 2 meds recall EL_22_A41_061-22.pdf (122KB)06/10/2022Download
 Sanofi is recalling all batches of the above product as a precautionary measure due to the identification of N-nitrosomethylphenylamine (NMPA) above the acceptable limit. Nitrosamines may increase... 
application/pdfMexilitenene_Class_1-Recall-2022-007.pdf (216KB)04/08/2022Download
 Information for HCP - ACTION NOW 
application/pdfMexilitene 50_100_200mg_caps Class 1 recall NatPSA-2022-007.pdf (200KB)04/08/2022Download
 National Patient Safety Alert 
application/pdfParoxetine 40mf fc tablets_crescent pharmac_ cl 2meds recall_270422.pdf (97KB)27/04/2022Download
application/pdfBeclometasone dip nasal spray Class 4 meds defect EL__22_A_14_Final150322.pdf (213KB)15/03/2022Download
 Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons. See Appendix 1 in this notification for detailed Braille information 
Page: [1] [2] [3]
[ Next » ]